Press Releases Phastar Scoops Multiple Finalist Positions in 2025 Scrip Awards October 1st, 2025 3 minute read Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as fi...
Press Releases Phastar Appoints Industry Veteran Billy Amzal as Head of Strategic Consulting June 24th, 2025 2 minute read London, UK, and Durham (NC), US – June 24th, 2025: Phastar, a global specialist biometrics & data science Contrac...
Press Releases Phastar Secures Finalist Spot at 2025 Citeline Awards April 10th, 2025 3 minute read London, UK, and Durham (NC), US – April 10th, 2025: Phastar, a global specialist biometrics & data science Contra...
Events PharmaSUG China February 23rd, 2026 1 minute read We are excited to be presenting at PharmaSUG in Shanghai, 24-25 July 2026 Design and Analysis of a Multi-Frequency PR...
Events JSM 2026 February 22nd, 2026 1 minute read Phastar is delighted to be attending JSM 2026, 1-6 August in Boston, MA Connect to meet with our team on site or join...
Events Medidata NEXT Shanghai 2026 February 21st, 2026 1 minute read Phastar is exhibiting at Medidata NEXT, 3 September 2026 in Shanghai, China Connect to meet with our team on site or ...
Webinars AI for Clinical Research Series – Prediction June 26th, 2026 1 minute read Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...
Webinars A Systematic Review into the Use of Bayesian Methods in Clinical Trials June 25th, 2026 2 minute read Bayesian methods continue to gain momentum as an alternative approach to traditional clinical trial design, yet many ...
Webinars AI for Automation and Digital Data Flow June 24th, 2026 1 minute read Automate Programming and QC Processes, Accelerating Operations and Evidence Generation This session will explore AI’s...
Case Studies Transforming Uncertainty into Statistical Confidence: Simulation-Driven Design for a First-in-Human Reproductive Therapeutic July 20th, 2026 1 minute read Designing a first-in-human study is challenging. Designing one for a novel reproductive therapy with limited prior da...
Case Studies Turning Complexity into Regulatory Confidence: Designing a Seamless Phase 2b/3 Strategy for FDA Engagement July 20th, 2026 1 minute read Accelerating clinical development requires more than speed, it demands a careful balance between innovation, scientif...
Case Studies Enabling First-in-Human Trial Success: Delivering an Innovative Bayesian Phase I/II Oncology Design July 20th, 2026 1 minute read Helping an Emerging Biotech Navigate Complex Clinical Development Preparing for a first-in-human clinical trial prese...
Articles & Interviews How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials July 6th, 2026 2 minute read Christian Schmidt, Associate Director at Phastar, explores how real-time data analytics is helping sponsors overcome ...
Articles & Interviews Why Predictive Analytics are Crucial for Effective EU-HTAR Implementation July 6th, 2026 2 minute read Billy Amzal, Head of Strategic Consulting at Phastar, examines the evolving EU Health Technology Assessment Regulatio...
Articles & Interviews Reactions to “Research Rising” on Clinical Trials Day 2026 June 17th, 2026 1 minute read To mark Clinical Trials Day 2026, Matt George, Senior Statistician, and Sam Hinsley, Statistics Manager at Phastar, h...
Blogs Casual Inference in Regulatory Decision Making and HTAs: Challenges and the Road Ahead July 15th, 2026 4 minute read How Regulators Evaluate Evidence in a Changing Data Landscape As clinical research evolves, causal inferen...
Blogs From Headcount to Outcomes: Rethinking the FSP Model for Scalable Clinical Development July 9th, 2026 6 minute read The Functional Service Provider (FSP) model has long been a cornerstone of clinical development outsourcing. Original...
Blogs Meet the Team: Lu Zhang, Associate Director, Programming July 3rd, 2026 3 minute read In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each te...
Publications Building Effective Partnerships Between Biotechs and CROs to Advance Clinical Development July 21st, 2026 1 minute read The biotech industry is evolving rapidly, with emerging companies leading the charge in clinical development. As outs...
Publications Flexible Dose-Finding in Early-Phase Oncology Combination Studies Enabling Mid-Trial Dose Insertions to Improve Dose Recommendations April 2nd, 2026 1 minute read Early-phase oncology combination trials often assume the optimal dose is already included in the dosing gri...
Publications Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence December 3rd, 2025 1 minute read As the pharmaceutical landscape evolves, traditional clinical trial designs are increasingly complemented by innovati...
